NASDAQ

Pharma

Migraine drug patents for Pozen’s Treximet upheld by judge

Migraine headache treatment Treximet, developed by pharmaceutical company Pozen (NASDAQ:POZN), has won a patent victory against generics companies looking to introduce their versions of the drug. A federal judge in Texas has ruled that two Treximet patents are valid and enforceable, and were infringed by Par Pharmaceutical (NYSE:PRX), Alphapharm and Dr. Reddy’s Laboratories (NYSE:RDY). A […]

Pharma

GSK’s HIV drug combivir to face generic from Teva

GlaxoSmithKline‘s (NYSE:GSK) HIV treatment combivir will soon face its first competition from a generic drug. Teva Pharmaceutical Industries (NASDAQ:TEVA) has received U.S. Food and Drug Administration approval on its application to market a generic version of combivir. Combivir is a combination drug that pairs azidothymidine, also known as AZT, with another antiviral, lamivudine. The combination […]

Hospitals

Ailing MedCath sells its last North Carolina hospital asset

MedCath (NASDAQ:MDTH) has sold another piece of its fragmenting hospital network — and its last remaining piece in North Carolina. New Hanover Regional Medical Center in Wilmington, North Carolina, has purchased MedCath’s ownership stake and management agreement in Coastal Carolina Heart for $5 million. Coastal Carolina Heart provides catheterization laboratory management services to the Wilmington […]